U.S. Biotech Stock News

Exxon Mobil (NYSE:XOM) has closed a $2.32b deal to acquire the FPSO ONE GUYANA for deployment in the Yellowtail development offshore Guyana. The vessel will continue to be operated by SBM Offshore under a long term arrangement, separating ownership from day to day operations. Exxon Mobil is also advancing a joint venture to build a major chemical recycling center in Houston, alongside progress toward larger chemical recycling capacity. Exxon Mobil, trading around $149.05, is set against a...

Why the latest Abu Dhabi move matters for State Street State Street (STT) has agreed with the Abu Dhabi Investment Office to build a new operating center in Al Ain, adding more than 300 financial services roles and deepening its presence in the UAE. For you as an investor, this is part of a broader effort that combines international expansion, product growth in areas like private credit ETFs, and management’s longer term Vision 2030 plan for the business. See our latest analysis for State...

If you are wondering whether Xylem's current share price lines up with its underlying value, you are not alone. Many investors are asking the same question right now. The stock most recently closed at US$142.12, with total returns of 3.1% over 7 days, 1.9% over 30 days, 3.7% year to date, 9.7% over 1 year, 38.7% over 3 years and 52.0% over 5 years. This performance is giving some investors fresh questions about growth potential and risk. Recent coverage around Xylem has focused on its role...

Vera Therapeutics (VERA) is entering a key transition period after naming Matt Skelton as Chief Commercial Officer, while its lead drug candidate atacicept moves through FDA Priority Review ahead of a July 7, 2026 PDUFA decision. See our latest analysis for Vera Therapeutics. At a share price of US$40.95, Vera Therapeutics has seen a 69.28% 90 day share price return and a very large 3 year total shareholder return, while the 30 day share price return of a 15.88% decline suggests recent...

Lesaka Technologies (NasdaqGS:LSAK) has reported Q2 2026 results that keep the focus firmly on revenue scale and ongoing losses, with quarterly revenue at US$171.4 million and EPS at a loss of US$0.05, while trailing 12 month figures show revenue of US$677.6 million and a net loss of US$84.3 million, or EPS of US$1.08 in losses. Over recent quarters, the company has seen revenue move from US$146.0 million in Q4 2024 to US$153.6 million in Q1 2025, US$146.8 million in Q2 2025, US$135.7 million...

Weatherford International’s fourth-quarter 2025 results, released on 3 February 2026, showed revenue of US$1,289 million and net income of US$138 million, beating analyst earnings expectations and supported by a 10% dividend increase to US$0.275 per share. Alongside the earnings beat, the company completed a US$200.01 million buyback program and secured multi‑year contracts across the Middle East and Latin America, underscoring management’s focus on capital returns and contract...

Maximus (MMS) opened fiscal Q1 2026 with total revenue of US$1.3b and basic EPS of US$1.71, underpinned by net income of US$93.9m. The company has seen quarterly revenue move from US$1.40b in Q1 2025 to US$1.35b in Q1 2026, while basic EPS over that same span has ranged from US$0.69 in Q1 2025 to US$1.71 in the latest quarter. This compares with a trailing twelve month EPS of US$6.62 and net income of US$371.8m. For investors, a key focus from this release is how these earnings and revenue...

Vita Coco Company (NasdaqGS:COCO) is being highlighted for its role as a global leader in functional hydration, supported by a flexible, scalable business model. Recent coverage explored how new tax rules that favor business investment could influence Vita Coco's future capital deployment and expansion plans. Co Founder Mike Kirban shared insights on brand building, competing against larger beverage players, and key milestones such as the company's IPO. Vita Coco operates in the functional...

Envista Holdings (NVST) has wrapped up FY 2025 with Q4 revenue of US$750.6 million and EPS of US$0.20, alongside trailing twelve month revenue of US$2.7 billion and EPS of US$0.28 that reflect the company’s recent move into positive earnings. The company has seen quarterly revenue move from US$652.9 million in Q4 2024 to US$750.6 million in Q4 2025, with quarterly EPS shifting from US$0.01 to US$0.20 over the same period. Trailing twelve month EPS moved from a large loss to a positive...

The Department of Homeland Security has begun rolling out body worn cameras for agents in Minnesota. DHS plans to extend body worn camera adoption nationwide over time. Axon Enterprise, a leading supplier of body cameras and evidence management tools, is positioned to compete for this expanded demand. For investors watching Axon Enterprise (NasdaqGS:AXON), the DHS rollout puts renewed attention on a company already closely tied to public safety technology. The stock trades around $414.2,...

Ventas (VTR) just posted its FY 2025 numbers with Q4 revenue of US$1.6 billion and basic EPS of US$0.15, while Q3 revenue was US$1.5 billion with basic EPS of US$0.14, setting a clear top line and per share earnings run rate for the year. Over the recent periods, reported revenue has moved from US$1.3 billion in Q1 2025 through US$1.4 billion in Q2 and US$1.5 billion in Q3 to US$1.6 billion in Q4, alongside basic EPS readings of US$0.11, US$0.15, US$0.14 and US$0.15, giving investors a clean...

Lionsgate Studios (LION) just posted Q3 2026 results with revenue of US$724.3 million and a basic EPS loss of US$0.16, alongside net income excluding extra items of a US$46.2 million loss that keeps profitability under pressure. The company has seen quarterly revenue move from US$970.5 million in Q3 2025 to US$724.3 million in Q3 2026, while basic EPS shifted from a loss of US$0.08 to a loss of US$0.16, so investors will be weighing how much of that shortfall is tied to margins rather than...

Exponent (NasdaqGS:EXPO) reported robust fourth quarter results with revenue growth and solid business momentum. The company announced an increase to its regular cash dividend, signaling a more shareholder focused capital return profile. Management highlighted new uses of artificial intelligence in both client work and internal operations as a key development. Exponent, a science and engineering consulting firm, sits at the intersection of technical expertise and real world problem solving...

Rockwell Automation (NYSE:ROK) has partnered with Lucid Motors to deploy its enterprise software at Lucid's manufacturing facility in Saudi Arabia. The deployment will support workforce development and production expansion tied to Saudi Vision 2030. The agreement extends Rockwell's presence in the electric vehicle sector and deepens its role in Saudi Arabia's industrial transformation. Rockwell Automation comes into this announcement with its shares at $415.02 and a 1 year return of 57.2%,...

Peabody Energy (BTU) closed FY 2025 with fourth quarter revenue of US$1.0 billion and basic EPS of US$0.07, alongside net income from continuing operations of US$9.6 million. The company reported quarterly revenue of US$1.12 billion and EPS of US$0.22 in Q4 2024 and US$1.02 billion and EPS of US$0.07 in Q4 2025. Trailing twelve month figures show revenue of US$3.9 billion and a net loss of US$52.7 million. For investors, the key takeaway is that profitability remains thin and margins look...

Essex Property Trust (ESS) has wrapped up FY 2025 with fourth quarter revenue of US$480.4 million, Basic EPS of US$1.25, and Funds From Operations of US$263.0 million, giving investors a clear read on both headline and REIT specific earnings power. Over recent quarters the company has seen revenue move from US$462.3 million in Q3 2024 to US$480.4 million in Q4 2025, and Basic EPS range between US$1.25 and US$4.01. Trailing twelve month revenue stands at about US$1.9 billion and EPS at...

Recent commentary around UP Fintech Holding (NasdaqGS:TIGR) focuses on its operational momentum, cash position above US$500 million, and modest trailing P/E as investors weigh the impact of its pivot toward international brokerage markets. See our latest analysis for UP Fintech Holding. At a share price of US$8.15, UP Fintech’s short term share price return has been weak, with a 30 day share price decline of 18.42% and a year to date share price decline of 21.93%, while its 1 year total...

Ingles Markets (IMKT.A) has opened Q1 2026 with total revenue of US$1.4 billion and basic EPS of US$1.48, with trailing twelve month EPS at US$5.01 on revenue of US$5.4 billion, setting a clear earnings benchmark for investors watching its recent rebound in profitability. The company has seen quarterly revenue move from US$1.29 billion and EPS of US$0.87 in Q1 2025 to US$1.37 billion and EPS of US$1.48 in Q1 2026, while trailing margins have edged higher, giving this update a more...

CF Bankshares (CFBK) has rounded out FY 2025 with fourth quarter total revenue of US$14.6 million and basic EPS of US$0.89, supported by trailing twelve month revenue of US$52.7 million and EPS of US$2.70 against a current share price of US$33.31. Over the past few reporting periods, the company has seen quarterly revenue move from US$12.6 million in Q4 2024 to US$13.5 million in Q1 2025, US$14.2 million in Q2 2025, US$10.4 million in Q3 2025, and US$14.6 million in Q4 2025. Basic EPS has...

COPT Defense Properties (CDP) has put up another steady set of numbers, with Q3 FY 2025 revenue of US$190.6 million and basic EPS of US$0.37, alongside funds from operations of US$80.0 million that remain central to how many investors look at this REIT. The company has seen revenue move from US$183.7 million in Q4 2024 to US$190.3 million in Q2 2025 and US$190.6 million in Q3 2025, while basic EPS has ranged between US$0.31 and US$0.37 over the same stretch, giving you a clear read on how...

In recent updates, Argan, Inc. reported strong past financial results, including sharply higher fiscal 2025 revenue, much higher net income, and a record project backlog, all supported by a zero-debt balance sheet. An interesting angle is how Argan’s four diversified subsidiaries across power plants, industrial fabrication, and telecom infrastructure appear to support both operational resilience and cash generation. With these results and the company’s record backlog in focus, we’ll explore...

Valero Energy (VLO) is back in the spotlight after fourth quarter 2025 results showed net income of US$1,134 million on sales of US$30,372 million, with earnings per share rising sharply year over year. See our latest analysis for Valero Energy. Investors have reacted strongly to the latest earnings, with the share price at US$202.68 after a 4.40% 1 day share price return and a 22.61% year to date share price return. The 1 year total shareholder return of 56.78% points to momentum that has...

Earlier this week, Jazz Pharmaceuticals reported practice-changing results from its HERIZON-GEA trial and outlined plans to submit a supplemental Biologics License Application in the first half of 2026 for first-line gastroesophageal adenocarcinoma treatment as both doublet and triplet therapy with priority review. An important angle for investors is the expectation that these data could support broad first-line use and potential guideline inclusion across overlapping gastrointestinal cancer...

Piper Sandler Companies (PIPR) has put up another solid quarter, with Q3 FY 2025 revenue of US$479.3 million and basic EPS of US$3.61, supported by trailing twelve month EPS of US$14.36 on revenue of US$1.7 billion. Over the past year, the firm has seen total revenue move from US$1.4 billion on trailing EPS of US$8.64 at Q2 2024 to US$1.7 billion on EPS of US$14.36 at Q3 2025, alongside one year earnings growth of 44.1%. With net profit margins improving to 13.8% from 10.8% over the last 12...